IBDEI2G9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41547,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,41547,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,41548,0)
 ;;=Z77.120^^159^2005^67
 ;;^UTILITY(U,$J,358.3,41548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41548,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,41548,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,41548,2)
 ;;=^5063318
 ;;^UTILITY(U,$J,358.3,41549,0)
 ;;=Z86.74^^159^2005^110
 ;;^UTILITY(U,$J,358.3,41549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41549,1,3,0)
 ;;=3^Personal Hx of Sudden Cardiac Arrest 
 ;;^UTILITY(U,$J,358.3,41549,1,4,0)
 ;;=4^Z86.74
 ;;^UTILITY(U,$J,358.3,41549,2)
 ;;=^5063478
 ;;^UTILITY(U,$J,358.3,41550,0)
 ;;=Z86.718^^159^2005^117
 ;;^UTILITY(U,$J,358.3,41550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41550,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism (DVT)
 ;;^UTILITY(U,$J,358.3,41550,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,41550,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,41551,0)
 ;;=Z96.1^^159^2005^127
 ;;^UTILITY(U,$J,358.3,41551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41551,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,41551,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,41551,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,41552,0)
 ;;=Z96.612^^159^2005^132
 ;;^UTILITY(U,$J,358.3,41552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41552,1,3,0)
 ;;=3^Presence of Left Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,41552,1,4,0)
 ;;=4^Z96.612
 ;;^UTILITY(U,$J,358.3,41552,2)
 ;;=^5063693
 ;;^UTILITY(U,$J,358.3,41553,0)
 ;;=Z96.611^^159^2005^137
 ;;^UTILITY(U,$J,358.3,41553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41553,1,3,0)
 ;;=3^Presence of Right Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,41553,1,4,0)
 ;;=4^Z96.611
 ;;^UTILITY(U,$J,358.3,41553,2)
 ;;=^5063692
 ;;^UTILITY(U,$J,358.3,41554,0)
 ;;=Z93.0^^159^2005^145
 ;;^UTILITY(U,$J,358.3,41554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41554,1,3,0)
 ;;=3^Tracheostomy Status
 ;;^UTILITY(U,$J,358.3,41554,1,4,0)
 ;;=4^Z93.0
 ;;^UTILITY(U,$J,358.3,41554,2)
 ;;=^5063642
 ;;^UTILITY(U,$J,358.3,41555,0)
 ;;=Z99.3^^159^2005^149
 ;;^UTILITY(U,$J,358.3,41555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41555,1,3,0)
 ;;=3^Wheelchair Dependence
 ;;^UTILITY(U,$J,358.3,41555,1,4,0)
 ;;=4^Z99.3
 ;;^UTILITY(U,$J,358.3,41555,2)
 ;;=^5063759
 ;;^UTILITY(U,$J,358.3,41556,0)
 ;;=A15.0^^159^2006^84
 ;;^UTILITY(U,$J,358.3,41556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41556,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,41556,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,41556,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,41557,0)
 ;;=B20.^^159^2006^31
 ;;^UTILITY(U,$J,358.3,41557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41557,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,41557,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,41557,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,41558,0)
 ;;=B02.9^^159^2006^93
 ;;^UTILITY(U,$J,358.3,41558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41558,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,41558,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,41558,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,41559,0)
 ;;=A60.9^^159^2006^2
 ;;^UTILITY(U,$J,358.3,41559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41559,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,41559,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,41559,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,41560,0)
 ;;=A60.04^^159^2006^34
 ;;^UTILITY(U,$J,358.3,41560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41560,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
